HULIO 40 mg/0.8 ml, solution for injection 2 bottles of 0.8 ml + 2 needles
Active ingredients: Adalimumab
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 bottles of 0.8 ml + 2 needlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HULIO 40 mg/0,8 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 flacons en verre de 0,8 mL + 2 seringues + 2 aiguilles + 2 adaptateurs pour flacon + 4 tampons d’alcool (conditionnement multiple)
- Marketing authorisation holder
- BIOSIMILAR COLLABORATIONS IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Jul 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63895021CIP73015742CIP133400930157428Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADALIMUMABsolution | 40 mg · un flacon unidose 0,8 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.